Early and late elevation of plasma atrial and brain natriuretic peptides in patients after bone marrow transplantation

N. Niwa, Eiichi Watanabe, M. Hamaguchi, Y. Kodera, H. Miyazaki, I. Kodama, M. Ohono

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Clinical usefulness of bone marrow transplantation (BMT) remains limited by myocardial damage during the post-transplantation period. Measurements of plasma atrial and brain natriuretic peptides (ANP, BNP) during the acute post-transplantation period could serve to monitor cardiac complications since these peptides are known to increase in heart failure depending on its severity. We prospectively analyzed ANP and BNP levels from 14 days before to 100 days after BMT in 46 consecutive patients undergoing allogeneic (n=42) and autologous (n=4) transplantation. Cardiac performance was assessed by echocardiography and radionuclide ventriculography. BNP and ANP levels of the patients on admission (baseline: day-14) were 16.3±13.3 pg/ml and 14.4±8.8 pg/ml, respectively. There were two different types of changes in the BNP and ANP levels. The 21 patients in group I showed dual peaks of elevation on day 1 (BNP=164.4±136.0 pg/ml, P<0.01; ANP=44.5± 35.4 pg/ml, NS) and day 14 (BNP=233.9±106.2 pg/ml, P<0.01; ANP=142.7±154.6 pg/ml, P<0.05), whereas the remaining 25 patients in group II had a single peak on day 1 (BNP=124.5±124.9 pg/ml, P<0.05; ANP=45.2±42.4 pg/ml, NS). The left ventricular ejection fraction on day 63 was unchanged in both groups of patients from the baselines. The time to peak filling rate, a parameter of diastolic function in the radionuclide ventriculography, was significantly prolonged in group I patients (by 30±53%), whereas unaffected in group II patients. These results suggest that plasma BNP monitoring for 2 weeks after BMT may be useful for early detection of patients at high risk for cardiac dysfunction in the post-transplantation period.

Original languageEnglish
Pages (from-to)460-465
Number of pages6
JournalAnnals of Hematology
Volume80
Issue number8
DOIs
Publication statusPublished - 01-09-2001

Fingerprint

Brain Natriuretic Peptide
Atrial Natriuretic Factor
Bone Marrow Transplantation
Transplantation
Radionuclide Ventriculography
Patient Admission
Stroke Volume
Echocardiography
Heart Failure
Peptides

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Niwa, N. ; Watanabe, Eiichi ; Hamaguchi, M. ; Kodera, Y. ; Miyazaki, H. ; Kodama, I. ; Ohono, M. / Early and late elevation of plasma atrial and brain natriuretic peptides in patients after bone marrow transplantation. In: Annals of Hematology. 2001 ; Vol. 80, No. 8. pp. 460-465.
@article{ac7f8b44606f4c3fa51d96a3d94806ba,
title = "Early and late elevation of plasma atrial and brain natriuretic peptides in patients after bone marrow transplantation",
abstract = "Clinical usefulness of bone marrow transplantation (BMT) remains limited by myocardial damage during the post-transplantation period. Measurements of plasma atrial and brain natriuretic peptides (ANP, BNP) during the acute post-transplantation period could serve to monitor cardiac complications since these peptides are known to increase in heart failure depending on its severity. We prospectively analyzed ANP and BNP levels from 14 days before to 100 days after BMT in 46 consecutive patients undergoing allogeneic (n=42) and autologous (n=4) transplantation. Cardiac performance was assessed by echocardiography and radionuclide ventriculography. BNP and ANP levels of the patients on admission (baseline: day-14) were 16.3±13.3 pg/ml and 14.4±8.8 pg/ml, respectively. There were two different types of changes in the BNP and ANP levels. The 21 patients in group I showed dual peaks of elevation on day 1 (BNP=164.4±136.0 pg/ml, P<0.01; ANP=44.5± 35.4 pg/ml, NS) and day 14 (BNP=233.9±106.2 pg/ml, P<0.01; ANP=142.7±154.6 pg/ml, P<0.05), whereas the remaining 25 patients in group II had a single peak on day 1 (BNP=124.5±124.9 pg/ml, P<0.05; ANP=45.2±42.4 pg/ml, NS). The left ventricular ejection fraction on day 63 was unchanged in both groups of patients from the baselines. The time to peak filling rate, a parameter of diastolic function in the radionuclide ventriculography, was significantly prolonged in group I patients (by 30±53{\%}), whereas unaffected in group II patients. These results suggest that plasma BNP monitoring for 2 weeks after BMT may be useful for early detection of patients at high risk for cardiac dysfunction in the post-transplantation period.",
author = "N. Niwa and Eiichi Watanabe and M. Hamaguchi and Y. Kodera and H. Miyazaki and I. Kodama and M. Ohono",
year = "2001",
month = "9",
day = "1",
doi = "10.1007/s002770100331",
language = "English",
volume = "80",
pages = "460--465",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "8",

}

Early and late elevation of plasma atrial and brain natriuretic peptides in patients after bone marrow transplantation. / Niwa, N.; Watanabe, Eiichi; Hamaguchi, M.; Kodera, Y.; Miyazaki, H.; Kodama, I.; Ohono, M.

In: Annals of Hematology, Vol. 80, No. 8, 01.09.2001, p. 460-465.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Early and late elevation of plasma atrial and brain natriuretic peptides in patients after bone marrow transplantation

AU - Niwa, N.

AU - Watanabe, Eiichi

AU - Hamaguchi, M.

AU - Kodera, Y.

AU - Miyazaki, H.

AU - Kodama, I.

AU - Ohono, M.

PY - 2001/9/1

Y1 - 2001/9/1

N2 - Clinical usefulness of bone marrow transplantation (BMT) remains limited by myocardial damage during the post-transplantation period. Measurements of plasma atrial and brain natriuretic peptides (ANP, BNP) during the acute post-transplantation period could serve to monitor cardiac complications since these peptides are known to increase in heart failure depending on its severity. We prospectively analyzed ANP and BNP levels from 14 days before to 100 days after BMT in 46 consecutive patients undergoing allogeneic (n=42) and autologous (n=4) transplantation. Cardiac performance was assessed by echocardiography and radionuclide ventriculography. BNP and ANP levels of the patients on admission (baseline: day-14) were 16.3±13.3 pg/ml and 14.4±8.8 pg/ml, respectively. There were two different types of changes in the BNP and ANP levels. The 21 patients in group I showed dual peaks of elevation on day 1 (BNP=164.4±136.0 pg/ml, P<0.01; ANP=44.5± 35.4 pg/ml, NS) and day 14 (BNP=233.9±106.2 pg/ml, P<0.01; ANP=142.7±154.6 pg/ml, P<0.05), whereas the remaining 25 patients in group II had a single peak on day 1 (BNP=124.5±124.9 pg/ml, P<0.05; ANP=45.2±42.4 pg/ml, NS). The left ventricular ejection fraction on day 63 was unchanged in both groups of patients from the baselines. The time to peak filling rate, a parameter of diastolic function in the radionuclide ventriculography, was significantly prolonged in group I patients (by 30±53%), whereas unaffected in group II patients. These results suggest that plasma BNP monitoring for 2 weeks after BMT may be useful for early detection of patients at high risk for cardiac dysfunction in the post-transplantation period.

AB - Clinical usefulness of bone marrow transplantation (BMT) remains limited by myocardial damage during the post-transplantation period. Measurements of plasma atrial and brain natriuretic peptides (ANP, BNP) during the acute post-transplantation period could serve to monitor cardiac complications since these peptides are known to increase in heart failure depending on its severity. We prospectively analyzed ANP and BNP levels from 14 days before to 100 days after BMT in 46 consecutive patients undergoing allogeneic (n=42) and autologous (n=4) transplantation. Cardiac performance was assessed by echocardiography and radionuclide ventriculography. BNP and ANP levels of the patients on admission (baseline: day-14) were 16.3±13.3 pg/ml and 14.4±8.8 pg/ml, respectively. There were two different types of changes in the BNP and ANP levels. The 21 patients in group I showed dual peaks of elevation on day 1 (BNP=164.4±136.0 pg/ml, P<0.01; ANP=44.5± 35.4 pg/ml, NS) and day 14 (BNP=233.9±106.2 pg/ml, P<0.01; ANP=142.7±154.6 pg/ml, P<0.05), whereas the remaining 25 patients in group II had a single peak on day 1 (BNP=124.5±124.9 pg/ml, P<0.05; ANP=45.2±42.4 pg/ml, NS). The left ventricular ejection fraction on day 63 was unchanged in both groups of patients from the baselines. The time to peak filling rate, a parameter of diastolic function in the radionuclide ventriculography, was significantly prolonged in group I patients (by 30±53%), whereas unaffected in group II patients. These results suggest that plasma BNP monitoring for 2 weeks after BMT may be useful for early detection of patients at high risk for cardiac dysfunction in the post-transplantation period.

UR - http://www.scopus.com/inward/record.url?scp=0034892596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034892596&partnerID=8YFLogxK

U2 - 10.1007/s002770100331

DO - 10.1007/s002770100331

M3 - Article

C2 - 11563591

AN - SCOPUS:0034892596

VL - 80

SP - 460

EP - 465

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 8

ER -